<DOC>
	<DOCNO>NCT00214084</DOCNO>
	<brief_summary>Obstructive sleep apnea ( OSA ) medical problem whose importance increase recognition awareness . The National Commission Sleep Disorders estimate 15 million Americans OSA , many remain undiagnosed ( 24 ) . OSA associate development hypertension cardiovascular disease ( 1,2 ) . Patients OSA , like congestive heart failure , hypertension , hypercholesterolemia diabetes , exhibit impaired EDV ( 25-32 ) . OSA also associate impairment endothelium-dependent cerebral blood flow response , may risk factor stroke ( 33 ) . Impaired EDV result reduce production inadequate action nitric oxide . Since EDV worsen disease progression improve disease treatment , serve prognostic marker vascular function ( 34-37 ) . In OSA , hypoxia neurohumoral disturbance increase generation reactive oxygen specie ( ROS ) neutralize nitric oxide impair endothelium-dependent response ( 9,10,38 ) . One source ROS endothelial cell enzyme xanthine oxidase ( 38 ) . XO enzyme present vascular endothelium significantly contribute generation ROS congestive heart failure , hypercholesterolemia diabetes ( 13-17 ) . Inhibition XO improve endothelium-dependent resistance vessel response population ( 13-17 ) , unknown XO significantly contribute oxidative stress endothelial dysfunction OSA . The central hypothesis application inhibition XO allopurinol reduce oxidative stress generation ROS , thereby improve nitric oxide bioavailability EDV OSA . Our hypothesis formulate basis patient OSA experience repeat hypoxemia increase activity XO enzymes , thus increase generation ROS negatively impact EDV . Hypoxia detrimental vascular homeostasis since increase generation ROS direct mechanism via activation XO .</brief_summary>
	<brief_title>Vascular Pathophysiology Obstructive Sleep Apnea</brief_title>
	<detailed_description />
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<criteria>Patients Sleep Disordered Breathing : Significant obstructive sleep apnea verify complete overnight polysomnography apneahypopnea index ( AHI ) &gt; 10 event per hour . Fasting total cholesterol &lt; 240 mg/dL Fasting blood glucose &lt; 120 mg/dL Control subject : Free sleep disorder breathe verified complete overnight polysomnography oxygen desaturation screening ( AHI &lt; 5 event per hour ) Fasting total cholesterol &lt; 240 mg/dL Fasting blood glucose &lt; 120 mg/dL Presence cardiovascular diseases medical condition affect vascular response ( sleep apnea ) Subject take vasoactive medication , willing stop taking vitamins supplement study participation Current smoker History adverse reaction allopurinol , acetylcholine , nitroprusside , verapamil lidocaine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>